The Online Investor
Medical Instruments & Supplies IPOs image Medical Instruments & Supplies IPOs » By The Online Investor Staff, updated Thu., Feb. 22, 9:26 AM
Recent initial public offerings in the Medical Instruments & Supplies IPOs category.

Slide #1. Obalon Therapeutics, Inc. Initial Public Offering

Company: Obalon Therapeutics, Inc.
Proposed Symbol: OBLN
Shares Offered: 5,000,000
Price Per Share: $15.00
Over-Allotment: 750,000
Description: Obalon Therapeutics, Inc., a commercial-stage medical device company focused on developing and commercializing innovative medical devices to treat obese and overweight people by facilitating weight loss, today announced the pricing of its initial public offering of 5,000,000 shares of its common stock at a price to the public of $15.00 per share. The shares are expected to begin trading on The NASDAQ Global Market on October 6, 2016 under the symbol "OBLN." In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 shares of common stock.

IPOs: Obalon Therapeutics, Inc.

List of Medical Instruments & Supplies IPOs in this Slideshow: Company Ticker IPO Date Atossa Genetics, Inc. ATOS 11/8/2012 Tandem Diabetes Care TNDM Inogen, Inc. INGN Amedica Corporation AMDA Quotient Limited QTNT ReWalk Robotics Ltd. RWLK IRadimed Corporation IRMD Intersect ENT, Inc. XENT 7/24/2014 T2 Biosystems, Inc. TTOO Nevro NVRO Second Sight Medical Products, Inc. EYES Histogenics Corporation HSGX Check-Cap Ltd. CHEK 2/19/2015 Entellus Medical, Inc. ENTL Presbia PLC LENS HTG Molecular Diagnostics HTGM Invuity IVTY Glaukos Corporation GKOS Glaukos Corporation GKOS Penumbra, Inc. PEN NovoCure Limited NVCR Pulse Biosciences, Inc. PLSE Tactile Systems Technology, Inc. TCMD Fulgent Genetics FLGT Obalon Therapeutics, Inc. OBLN

Medical Instruments & Supplies IPOs Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2018, All Rights Reserved Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.